Primary care clinics, multi-specialty hospitals / medical centres, and super-specialty hospitals are the main venues through which Max Healthcare Institute Limited offers
Categories
Healthcare
Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Executive Director Sunil
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript
Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen -- Chairman and Managing Director Alisha Moopen -- Deputy
Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript
Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra -- Senior Vice President, Investor Relations Ashutosh Raghuvanshi -- Managing
Lupin Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing its US
Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer Satakarni
Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year
Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the previous year.
Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript
Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations and Sustainability
MedPlus Health Services Ltd (MEDPLUS) Q3 FY23 Earnings Concall Transcript
MedPlus Health Services Ltd (NSE:MEDPLUS) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Prasad Reddy Battinapatla -- Assistant Financial Controller Gangadi Madhukar
AMI Organics Ltd (AMIORG) Q3 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE: AMIORG) Q3 FY23 Earnings Concall dated Feb. 04, 2023 Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Patel -- Chief Executive
Aarti Industries Ltd (AARTIIND) Q3 FY23 Earnings Concall Transcript
Aarti Industries Ltd (NSE: AARTIIND) Q3 FY23 Earnings Concall dated Feb. 06, 2023 Corporate Participants: Nishid Solanki -- Investor Relations Rajendra Gogri -- Chairman and Managing
Zydus Lifesciences Ltd (ZYDUSLIFE) Q3 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE:ZYDUSLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Ganesh N. Nayak -- Executive Director Sharvil P. Patel -- Managing Director
Emami Limited (EMAMILTD) Q3 FY23 Earnings Concall Transcript
Emami Limited (NSE:EMAMILTD) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Mohan Goenka -- Vice Chairman & Whole-Time Director Gul Raj Bhatia -- President,
Divi’s Laboratories Ltd (DIVISLAB) Q3 FY23 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY23 Earnings Concall dated Feb. 03, 2023 Corporate Participants: M. Satish Choudhury -- Company Secretary and Chief Investor
Max Healthcare Q3FY23; 7% Growth in Profits
Max Healthcare Institute Ltd.’s gross revenue in Q3FY23 rose 13% to ₹ 1,559 crores. Consolidated Profit After Tax came at ₹ 269
Hester Biosciences Limited (HESTERBIO) Q3 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q3 FY23 Earnings Concall dated Jan. 31, 2023. Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing Director Priya
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q3 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY23 Earnings Concall dated Jan. 31, 2023 Corporate Participants: Abhishek Sharma -- Head of Investor Relations and
Torrent Pharmaceuticals Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Management Update: [00:05:39] TORNTPHARM said the company expects to file about
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon -- Executive Director, (Finance) and Chief Financial